Open House Drug Discount Agreements Budesonid

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Jun 03, 2027 · 279 days left·Open·Supplies·Framework

Structured notice only

Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Budesonid, ATC A07EA06

50/100

Opportunity Score

Needs reviewLow complexity

SuppliesFrameworkOpen

Why this score?

Opportunity

50 / 100

Complexity

20 / 100

Risk factors

Open-house agreements may be superseded by other discount contracts, causing early termination without compensation.

Strict submission requirements (paper originals, qualified electronic signature, monthly deadlines) could slow down con...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

Description
Industries & Services
Capabilities
Market & Experience
Certifications

Overview

Moderate opportunity

Key Facts

Framework procurement
Supplies contract
1 lot
Duration until Jul 2027
Non-exclusive drug discount agreements for Budesonid (ATC A07EA06) with AOK Bayern.
All interested pharmaceutical companies meeting eligibility may join at any time until 03.06.2027.

Show full summary

Open-house model for non-exclusive drug discount agreements (Budesonid, ATC A07EA06) with AOK Bayern. Not a formal procurement procedure; any eligible pharmaceutical company can join. Contract runs from 01.08.2025 to 31.07.2027, with possible earlier termination. Submission requires signed contract, product list, and reliability declaration (paper or qualified electronic signature). No estimated value provided.

Risks

Open-house agreements may be superseded by other discount contracts, causing early termination without compensation.

Strict submission requirements (paper originals, qualified electronic signature, monthly deadlines) could slow down con...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Eligibility

Only pharmaceutical companies eligible.

Administrative

Submission of signed contract, product list ('Festlegung der vertragsgegenständlichen Arzneimittel'), and signed reliability declaration.
Acceptable submission methods: original paper (2 copies) or electronic with qualified electronic signature via DTVP portal.

Requirements may be incomplete.

Award Criteria

Lot 1

No award criteria – open house model: any eligible company can join.

Buyer

Name

AOK Bayern - Die Gesundheitskasse

Location

München, DEU

[email protected]

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open House Drug Discount Agreements Budesonid

Single lot covering Budesonid (ATC A07EA06) discount agreements. Non-exclusive, open to all eligible pharmaceutical companies. Contracting ongoing until 03.06.2027.

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jul 2025 - Jul 2027

Procurement Details

Publication date: 15 Jun 2025
Languages: German

Reference metadata

Legal basis: 32014L0024

Reference IDs

Tender ID: 387722-2025

Documents (2)

Procurement document 1 Submission portal 1

Similar tenders

Bulgaria – Pharmaceutical products – Динамична система за покупки за доставка на лекарствени продукти за Медицински институт на МВР

Jul 9

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells über Arzneimittel mit dem Handelsnamen Oralair(R) (ATC-Code nach WHO: V01AA02)

Aug 31

Germany – Pharmaceutical products – Abschluss nicht exkl. Arzneimittel-Rabattvereinb. nach § 130a Abs. 8 SGB V im Wege eines Open-House-Modells zum Wirkstoff Ipratropiumbromid (ATC-Code nach WHO: R03BB01)

Sep 30

Denmark – Pharmaceutical products – Amgros 2027 1.1170.a

Sep 3